Presenilins and Alzheimer's disease
暂无分享,去创建一个
[1] Kenneth S. Kosik,et al. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology , 1996, Nature Medicine.
[2] J. Rommens,et al. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. , 1996, Human molecular genetics.
[3] B. Hyman,et al. Developmental Regulation of Presenilin mRNA Expression Parallels Notch Expression , 1997, Journal of neuropathology and experimental neurology.
[4] J. Growdon,et al. A novel presenilin‐1 mutation: Increased β‐amyloid and neurofibrillary changes , 1997 .
[5] E. M. Johnson. Possible role of neuronal apoptosis in Alzheimer's disease , 1994, Neurobiology of Aging.
[6] Allan I. Levey,et al. Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo , 1996, Neuron.
[7] K. Imahori,et al. Characterization of human presenilin 1 using N‐terminal specific monoclonal antibodies: Evidence that Alzheimer mutations affect proteolytic processing , 1996, FEBS letters.
[8] C. Broeckhoven. Presenilins and Alzheimer disease , 1995, Nature Genetics.
[9] M. Pericak-Vance,et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.
[10] D. Borchelt,et al. Protein Topology of Presenilin 1 , 1996, Neuron.
[11] J. Hardy,et al. The presenilins and Alzheimer's disease. , 1997, Human molecular genetics.
[12] M. Hayden,et al. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract , 1996, Nature Genetics.
[13] D. Selkoe,et al. Amyloid β-Protein and the Genetics of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.
[14] T. Ghayur,et al. Generation of Anti-apoptotic Presenilin-2 Polypeptides by Alternative Transcription, Proteolysis, and Caspase-3 Cleavage* , 1997, The Journal of Biological Chemistry.
[15] Y. Ihara,et al. Intracellular Generation and Accumulation of Amyloid β-Peptide Terminating at Amino Acid 42* , 1997, The Journal of Biological Chemistry.
[16] J. Weber,et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. , 1992, Science.
[17] P. Greengard,et al. Evidence for phosphorylation and oligomeric assembly of presenilin 1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[18] G. Caruso,et al. Démence présénile d'Alzheimer transmise dans une famille étendue. , 1985 .
[19] D. Pollen,et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14 , 1992, Nature Genetics.
[20] R. Doms,et al. Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells , 1997, Nature Medicine.
[21] P E Fraser,et al. Analysis of the 5' sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease. , 1997, Genomics.
[22] M. Staufenbiel,et al. Developmental Regulation of Presenilin-1 Processing in the Brain Suggests a Role in Neuronal Differentiation* , 1997, The Journal of Biological Chemistry.
[23] A D Roses,et al. Apolipoprotein E alleles as risk factors in Alzheimer's disease. , 1996, Annual review of medicine.
[24] D. Harris,et al. Evidence for a Six-transmembrane Domain Structure of Presenilin 1* , 1997, The Journal of Biological Chemistry.
[25] Jinhe Li,et al. Alzheimer Presenilins in the Nuclear Membrane, Interphase Kinetochores, and Centrosomes Suggest a Role in Chromosome Segregation , 1997, Cell.
[26] M. Mattson,et al. Alzheimer's PS‐1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β‐peptide , 1996, Neuroreport.
[27] D. Selkoe,et al. Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase C. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[28] C. Broeckhoven,et al. Mapping of a gene predisposing to early–onset Alzheimer's disease to chromosome 14q24.3 , 1992, Nature Genetics.
[29] M. Adams,et al. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene , 1995, Neuroreport.
[30] R. Tanzi,et al. REVIEWThe Gene Defects Responsible for Familial Alzheimer's Disease , 1996, Neurobiology of Disease.
[31] T. Sunderland,et al. Participation of Presenilin 2 in Apoptosis: Enhanced Basal Activity Conferred by an Alzheimer Mutation , 1996, Science.
[32] Weiming Xia,et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice , 1997, Nature Medicine.
[33] Brian J Cummings,et al. Immunohistochemical evidence for apoptosis in Alzheimer's disease. , 1994, Neuroreport.
[34] D. Price,et al. Expression of Presenilin 1 and 2 (PS1 and PS2) in Human and Murine Tissues , 1996, The Journal of Neuroscience.
[35] C. Masters,et al. Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides , 1997, Nature Medicine.
[36] D. Borchelt,et al. Endoproteolysis of Presenilin 1 and Accumulation of Processed Derivatives In Vivo , 1996, Neuron.
[37] Claudia H. Kawas,et al. The epidemiology of dementia and Alzheimer disease. , 1994 .
[38] J. Growdon,et al. Transmission and age‐at‐onset patterns in familial Alzheimer's disease , 1990, Neurology.
[39] T. Tabira,et al. Missense mutation of S182 gene in Japanese familial Alzheimer's disease , 1995, The Lancet.
[40] J. Rommens,et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.
[41] T. Iwatsubo,et al. The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[42] M. Adams,et al. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families , 1995, Nature Genetics.
[43] E M Wijsman,et al. A familial Alzheimer's disease locus on chromosome 1 , 1995, Science.
[44] D. Price,et al. Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesoderm , 1997, Nature.
[45] S. M. Sumi,et al. Amyloid (Aβ) deposition in chromosome 1–linked Alzheimer's disease: The volga german families , 1997, Annals of neurology.
[46] M. H. Angelis,et al. Maintenance of somite borders in mice requires the Delta homologue Dll1 , 1997, Nature.
[47] G. Schellenberg,et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.
[48] S. L'Hernault,et al. Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions , 1992, The Journal of cell biology.
[49] P. S. St George-Hyslop,et al. Phosphorylation, Subcellular Localization, and Membrane Orientation of the Alzheimer's Disease-associated Presenilins* , 1997, The Journal of Biological Chemistry.
[50] G. Schellenberg,et al. Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.
[51] John Hardy,et al. Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.
[52] D. Selkoe,et al. Enhanced Production and Oligomerization of the 42-residue Amyloid β-Protein by Chinese Hamster Ovary Cells Stably Expressing Mutant Presenilins* , 1997, The Journal of Biological Chemistry.
[53] C. Broeckhoven,et al. Molecular genetics of Alzheimer disease : identification of genes and gene mutations , 1995 .
[54] R. Tanzi,et al. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. , 1997, Science.
[55] D. Selkoe,et al. The Alzheimer’s Disease-Associated Presenilins Are Differentially Phosphorylated Proteins Located Predominantly within the Endoplasmic Reticulum , 1996, Molecular medicine.
[56] B. Keats,et al. Familial Alzheimer's disease in two kindreds of the same geographic and ethnic origin A clinical and genetic study , 1981, Journal of the Neurological Sciences.
[57] K. Beyreuther,et al. Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and β-amyloid precursor protein , 1997, Nature Medicine.
[58] Iva Greenwald,et al. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene , 1995, Nature.
[59] C. Haass,et al. Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing. , 1997, Genes and function.
[60] J. Rommens,et al. Two homologous genes causing early-onset familial Alzheimer's disease. , 1996, Cold Spring Harbor symposia on quantitative biology.
[61] R. Sherrington,et al. Presenilin Proteins Undergo Heterogeneous Endoproteolysis between Thr291and Ala299and Occur as Stable N- and C-Terminal Fragments in Normal and Alzheimer Brain Tissue , 1997, Neurobiology of Disease.
[62] J. Rossant,et al. Notch1 is required for the coordinate segmentation of somites. , 1995, Development.
[63] I. Greenwald,et al. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[64] N. Perrimon,et al. Interaction Between Wingless and Notch Signaling Pathways Mediated by Dishevelled , 1996, Science.
[65] A. LeBlanc. Apoptosis and Alzheimer’s Disease , 1997 .
[66] M. Lovett,et al. Presenilin 1 interaction in the brain with a novel member of the Armadillo family , 1997, Neuroreport.
[67] P. Vito,et al. Interfering with Apoptosis: Ca2+-Binding Protein ALG-2 and Alzheimer's Disease Gene ALG-3 , 1996, Science.
[68] R. Sherrington,et al. Misserise mutation of S182 gene in Italian families with early-onset Alzheimer's disease , 1995, The Lancet.
[69] G. Schellenberg,et al. Genomic structure and expression of STM2, the chromosome 1 familial Alzheimer disease gene. , 1996, Genomics.
[70] R. Tanzi,et al. Endoproteolytic Cleavage and Proteasomal Degradation of Presenilin 2 in Transfected Cells* , 1997, The Journal of Biological Chemistry.
[71] J. Trojanowski,et al. Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[72] B. Hyman,et al. Alzheimer–associated presenilins 1 and 2 : Neuronal expression in brain and localization to intracellular membranes in mammalian cells , 1996, Nature Medicine.
[73] S. Tonegawa,et al. Skeletal and CNS Defects in Presenilin-1-Deficient Mice , 1997, Cell.
[74] J. Hardy,et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1 , 1996, Nature.
[75] C. Cotman,et al. Alzheimer‐associated presenilin‐2 confers increased sensitivity to poptosis in PC12 cells , 1996, FEBS letters.
[76] D. Pollen,et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.
[77] C. Haass. Presenilins: Genes for Life and Death , 1997, Neuron.
[78] J. Olivo,et al. Cellular Expression and Proteolytic Processing of Presenilin Proteins Is Developmentally Regulated During Neuronal Differentiation , 1997, Journal of neurochemistry.
[79] S. M. Sumi,et al. Amyloid β protein (Aβ) deposition in chromosome 14–linked Alzheimer's disease: Predominance of Aβ42(43) , 1996 .
[80] C. L. Harris,et al. Evidence That Levels of Presenilins (PS1 and PS2) Are Coordinately Regulated by Competition for Limiting Cellular Factors* , 1997, The Journal of Biological Chemistry.
[81] E. Rogaev,et al. Cloning and characterization of the Drosophila presenilin homologue , 1997, Neuroreport.
[82] Hugo Vanderstichele,et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein , 1998, Nature.
[83] D. Selkoe,et al. Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[84] J. Hardy,et al. Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. , 1997, Human molecular genetics.